Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children
Recruiting
Phase 3
Interventional Study
Helicobacter Pylori Infection
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- Up to 18
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- Tanta University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Study of Nitazoxanide (NTZ) based therapeutic regimens for Helicobacter pylori in children
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
\- Positive helicobacter infection.
Exclusion Criteria:
* Previous treatment for H. Pylori.
Contacts